EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incomplete linkage disequilibrium between DPYD HapB3 variants: implications for pharmacogenetic phenotype assignment

Miguel Álvarez-Montero, Fiorela C. Dueñas-López, Ramón Pardo-Puras, Tania S. Rubio-Lepe, Elena Diago-Sempere, Pedro Arias, Belén Ferrer-Martínez, Ismael Ghanem, Lucía de Dios-Blázquez, Carlos Rodríguez-Antolín, Irene García-García, Rocío Rosas-Alonso und 1 weitere

Frontiers in Pharmacology · 06.11.2026 · 17

DOI: 10.3389/fphar.2026.1954600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.11.2026. Verfasst von Miguel Álvarez-Montero und 12 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reduced dihydropyrimidine dehydrogenase (DPD) activity is a major determinant of severe fluoropyrimidine-associated toxicity. The DPYD HapB3 haplotype is commonly identified through the synonymous variant c.1236G>A (rs56038477), which has traditionally been used as a proxy for the functional intronic variant c.1129–5923C>G (rs75017182). However, emerging evidence suggests that the linkage between these variants may not be absolute, potentially leading to inaccurate haplotype assignment. This study aimed to determine the frequency of clinically relevant DPYD variants in our population and to assess concordance between c.1236G>A and c.1129–5923C>G.

Methods

We conducted a retrospective observational study including 3276 individuals who underwent routine pharmacogenetic testing. Genotyping was performed using the OpenArray™ platform. Allele and genotype frequencies of clinically relevant DPYD variants were calculated, and concordance between c.1236G>A and c.1129–5923C>G was evaluated. Samples showing discordant or atypical HapB3-associated genotypes were subjected to confirmatory analysis by next-generation sequencing (NGS).

Results

Allele frequencies were consistent with those reported in European and Spanish populations. One biologically discordant genotype configuration was identified among 3276 individuals, in which c.1236G>A was detected in the absence of c.1129–5923C>G; this finding was confirmed by NGS. A second apparently discordant case, initially classified as homozygous for c.1129–5923C>G but heterozygous for c.1236G>A, was attributed to automated genotype misclassification by the Thermo Fisher Connect Platform. NGS analysis subsequently demonstrated homozygosity for both variants, whereas review of the cluster plot revealed atypical fluorescence patterns likely responsible for the erroneous automated genotype call. These findings indicate that, in our population, incomplete linkage disequilibrium between these variants, as well as technical limitations of genotyping platforms, may compromise accurate HapB3 characterization.

Conclusion

Concordance between the HapB3-associated variants c.1236G>A and c.1129–5923C>G is extremely high but not absolute. Apparent HapB3 discordance may result from either rare biological dissociation or technical genotype misclassification, both of which can affect DPYD phenotype assignment. These findings support direct genotyping of c.1129–5923C>G whenever feasible and orthogonal confirmation of atypical or discordant genotyping results.

Zitieren

APA

Álvarez-Montero, M., Dueñas-López, F. C., Pardo-Puras, R., Rubio-Lepe, T. S., Diago-Sempere, E., Arias, P., Ferrer-Martínez, B., Ghanem, I., Dios-Blázquez, L. D., Rodríguez-Antolín, C., García-García, I., Rosas-Alonso, R., & Borobia, A. M. (2026). Incomplete linkage disequilibrium between DPYD HapB3 variants: implications for pharmacogenetic phenotype assignment. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1954600

Vancouver

Álvarez-Montero M, Dueñas-López FC, Pardo-Puras R, Rubio-Lepe TS, Diago-Sempere E, Arias P, et al. Incomplete linkage disequilibrium between DPYD HapB3 variants: implications for pharmacogenetic phenotype assignment. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1954600

BibTeX
@article{lvarezMontero2026,
  author = {Álvarez-Montero, Miguel and Dueñas-López, Fiorela C. and Pardo-Puras, Ramón and Rubio-Lepe, Tania S. and Diago-Sempere, Elena and Arias, Pedro and Ferrer-Martínez, Belén and Ghanem, Ismael and Dios-Blázquez, Lucía de and Rodríguez-Antolín, Carlos and García-García, Irene and Rosas-Alonso, Rocío and Borobia, Alberto M.},
  title = {Incomplete linkage disequilibrium between DPYD HapB3 variants: implications for pharmacogenetic phenotype assignment},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1954600}
}
Kostenlos starten →